One piece of pozi news that could come out earlier than that is more subtle but would speak volumes and that is either the current the 174 pt trial pozi trial adding 1st line pts, or a new trial for 1st-line pts and/or either of these clinical updates including a PR. Just thinking out loud here on what was discussed at the 3rd Q CC i.e that they were meeting w the FDA this month and the possibility of amending the 174 pt trial protocol to go after 1st-line patients.